University Hospitals Birmingham NHS Foundation Trust

Chapters

Status Drug name NICE TAs Comments
Status: Red 8-Methoxypsoralen 10mg tablets
Status: Red Acitretin capsules
Status: Red Adalimumab#13.5
Status: Red Alitretinoin 30mg capsules
Status: Red Apremilast
Status: Amber Azathioprine#13.5

Azathioprine Dermatology ESCA
Status: Red Baricitinib (Olumiant®)#Chapter13
Status: Red Bimekizumab
Status: Green Calcipotriol 50 microgram/g ointment
Status: Green Calcipotriol 50 microgram/ml scalp solution
Status: Amber Calcitriol ointment
Status: Amber Ciclosporin#13.5

Ciclosporin dermatology ESCA
Status: Amber Coal tar 5% lotion (Exorex®)
Status: Red Deucravacitinib
Status: Amber Dithranol cream
Status: Red Dithranol in lassar's paste

Unlicensed specials available in varying strengths
Status: Amber Dovobet gel
Status: Amber Dovobet ointment
Status: Red Etanercept
Status: Red Fumaderm tablets
Status: Red Guselkumab
Status: Red Hydroxycarbamide
Status: Amber Hydroxychloroquine
Status: Red Infliximab#13.5
Status: Red Ixekizumab (Taltz®)
Status: Grey Lebrikizumab
Status: Amber Methotrexate#13.5

ESCA
Status: Red Methoxypsoralen-5 20mg tablets
Status: Amber Mycophenylate

ESCA
Status: Grey Nemolizumab (Nemluvio®)
Status: Red Omalizumab#13.5
Status: Amber Pimecrolimus cream
Status: Green Polytar emollient
Status: Green Psoriderm emulsion
Status: Red Risankivzub (Skyrizi®)
Status: Red Ritlecitinib
Status: Red Salicylic acid 2% in white soft paraffin (100g)
Status: Green Sebco®
Status: Red Secukinumab
Status: Grey Spesolimab (Spevigo®)
Status: Amber Tacrolimus 0.03% ointment (30g)
Status: Amber Tacrolimus 0.1% ointment (30g)
Status: Red Thalidomide
Status: Red Tildrakizumab
Status: Red Ustekinumab#13.5
Building healthier lives
Back to top